Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TransNiDeG
DRKS00031704Phase 2Recruiting
- Sponsor
- Universitätsklinikum Bonn
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pancreatic cancer (PC), small bowel cancer and biliary cancer comparing Nicotinell patch with Placebo patch (2 arms). Started Aug 2023; status: recruiting.
02
Drugs
nicotine
03
Conditions
pancreatic cancer (PC)small bowel cancerbiliary cancer
Beyond the preview
Go deeper on DRKS00031704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031704.